Document Type
Case Report
Abstract
SINOVAC is an inactivated virus COVID 19 vaccine given emergency authorization for COVID-19 Pandemic. Different adverse reactions have been seen in after-marketing of COVID-19 vaccines. Here we present a case of patient who developed cerebral venous sinus thrombosis two weeks after the first dose of SINOVAC vaccine.
Recommended Citation
Khan, Soban; Khalil, Maryam; and Waqar, Zaid
(2022)
"Post Covid-19 Vaccine (Sinovac) Cerebral Venous Sinus Thrombosis,"
Pakistan Journal of Neurological Sciences (PJNS): Vol. 17:
Iss.
2, Article 4.
Available at:
https://ecommons.aku.edu/pjns/vol17/iss2/4
